Nutex Health, Inc.

NUTX

NUTXNutex Health, Inc. US flag

NASDAQ Capital Market

147.08

USD

+2.68

- -

875.76MMarket Cap

Profitability (USD)

MCP API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	257.69	- -	- -	- -	- -
Return on Assets (%)	- -	43.45	37.71	-102.8	-11.03	9.89	9
Return on Capital (%)	- -	41.12	36.07	- -	- -	-69.77	-22.56
Return on Invested Capital (%)	- -	65.34	51.77	- -	- -	26.09	30.45
Gross Margin (%)	100	57.51	54.08	7.03	14.04	40.89	50.76
EBITDA Margin (%)	38.32	58.05	54.74	3.9	6.49	32.66	33.84
Operating Margin (%)	35.76	55.9	52.43	-2.09	-0.61	28.71	31.49
Incremental Operating Margin (%)	- -	66.94	35.9	- -	- -	59.96	34.87
Pretax Margin (%)	33.06	53.18	51.12	-191.36	-19.58	22.88	27.97
Profit Margin (%)	21.56	38.67	39.99	-193.7	-18.49	10.85	8.09
Net Income to Common Margin (%)	21.56	38.67	39.99	-193.7	-18.49	10.85	8.09
Effective Tax Rate (%)	- -	0.12	0.57	- -	- -	13.68	26.32
Dvd Payout Ratio (%)	43.7	31.89	70.6	-11.63	-12.7	4.68	25.62
Sustainable Growth Rate (%)	- -	- -	75.77	- -	- -	- -	- -

Credit (USD)

MCP API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	120	150	179	267	276	340	351
ST Debt	64	20	13	21	20	28	23
LT Debt	56	130	165	246	256	313	328
Total Debt/EBITDA	3.23	0.94	0.98	31.24	17.15	2.17	1.19
Net Debt/EBITDA	1.24	0.47	0.29	0.46	1.15	- -	-0.48
Total Debt/EBIT	3.46	0.98	1.03	-58.36	-182.74	2.47	1.27
Net Debt/EBIT	1.33	0.49	0.3	-0.87	-12.26	- -	-0.52
EBITDA to Interest Expense	10.53	24.73	29.29	0.68	0.99	7.86	13.32
EBITDA-CapEx/Interest Expense	1.39	15.22	23.33	-0.49	0.4	7.75	13.21
EBIT to Interest Expense	9.83	23.81	28.05	-0.37	-0.09	6.91	12.4
Interest Expense	4	6	6	12	16	20	22
Common Equity/Total Assets	- -	- -	26.08	-83.99	-102.72	-54.47	-31.16
Long-Term Debt/Equity (%)	110.66	88.03	86.32	204.53	323.21	165.79	77.48
Long-Term Debt/Capital (%)	39.49	61.29	46.14	-346.78	-221.07	792.9	206.08
Long-Term Debt/Total Assets (%)	31.39	42.05	41.9	57	64.2	47.7	35.72
Total Debt/Equity (%)	235.94	101.87	93.2	222.06	348.59	180.5	82.99
Total Debt/Capital (%)	84.19	70.92	49.82	-376.5	-238.42	863.26	220.72
Total Debt/Total Assets (%)	66.92	48.65	45.24	61.89	69.24	51.93	38.26
Net Debt to Equity	90.93	50.92	27.63	3.3	23.38	-0.12	-33.61
Net Debt/Capital (%)	34.38	40.3	16.43	-3.77	-13.43	18.44	539.7
EBITDA	37	159	181	9	16	157	296
EBITDA-CapEx	5	98	145	-6	7	154	294
Operating Income (Loss)	35	153	174	-5	-2	138	276

Liquidity (USD)

MCP API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.11	0.81	0.96	0.62	0.38	0.26	1.18
Current Ratio	0.63	4.31	4.09	1.79	1.56	1.9	3.41
Quick Ratio	0.61	4.25	4	1.69	1.45	1.79	3.24
CFO/Avg Current Liab	- -	1.67	5.02	1.09	0.02	0.22	1.59
Common Equity/Total Assets	- -	- -	26.08	-83.99	-102.72	-54.47	-31.16
Long-Term Debt/Equity (%)	110.66	88.03	86.32	204.53	323.21	165.79	77.48
Long-Term Debt/Capital (%)	39.49	61.29	46.14	-346.78	-221.07	792.9	206.08
Long-Term Debt/Total Assets (%)	31.39	42.05	41.9	57	64.2	47.7	35.72
Total Debt/Equity (%)	235.94	101.87	93.2	222.06	348.59	180.5	82.99
Total Debt/Capital (%)	84.19	70.92	49.82	-376.5	-238.42	863.26	220.72
Total Debt/Total Assets (%)	66.92	48.65	45.24	61.89	69.24	51.93	38.26
CFO/Total Liabilities	9.44	53.77	85.41	16.25	0.39	4.96	50.12
CFO/CapEx	0.38	1.42	4.7	3.46	0.13	10.05	98.23
Altman's Z-Score	1.01	2.94	3.02	1.68	-0.59	1.17	3.35

Working Capital (USD)

MCP API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	3.8	2.97	2.53	4.09	3.21	3.12
Days Sales Outstanding	- -	96.09	122.7	144.04	89.24	113.63	117.07
Inventory Turnover	- -	88.68	67.07	64.24	61.49	90.92	150.8
Days Inventory Outstanding	- -	4.12	5.44	5.68	5.94	4.01	2.42
Accounts Payable Turnover	- -	16.85	11.67	9.06	8.06	15.86	14.51
Accounts Payable Turnover Days	- -	21.66	31.28	40.3	45.31	23.01	25.15
Cash Conversion Cycle	- -	78.54	96.86	109.41	49.87	94.63	94.35
Inventory to Cash Days	- -	91.97	117.26	138.35	83.3	109.61	114.65
Inventories	1	2	3	4	3	3	3
Raw Materials	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -
Other Inventory	1	2	3	4	3	3	3

Enterprise Value (USD)

MCP API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	1,205	118	161	1,047
- Cash & Cash Equivalents	8	26	36	34	22	41	186
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	23	62	77	24	18	56	94
+ Total Debt	120	150	179	267	276	340	351
Enterprise Value	134	186	219	1,462	389	517	1,307
Total Capital	142	212	358	-71	-116	39	159
Total Debt/Capital (%)	84.19	70.92	49.82	-376.5	-238.42	863.26	220.72
Total Debt / EV	0.89	0.81	0.81	0.18	0.71	0.66	0.27
EV/Sales	1.39	0.68	0.66	6.67	1.57	1.08	1.49
EV/EBITDA	3.62	1.17	1.21	170.94	24.2	3.3	4.41
EV/EBIT	3.87	1.22	1.26	- -	- -	3.75	4.74
EV/Cash Flow to Firm	8.59	2	1.22	23.03	24.52	12.81	4.94
EV/Free Cash Flow to Firm	2.81	1.21	1.01	18.72	15.34	12.12	4.89
Diluted Market Cap	- -	- -	- -	1,205	118	170	1,112
Diluted Enterprise Value	134	186	219	1,462	389	526	1,372
EV per Share	31.33	43.38	51.11	345.9	89.24	101.57	205.46
TTM Sales	97	274	332	219	248	480	875
TTM EBITDA	37	159	181	9	16	157	296
TTM Operating Income	35	153	174	-5	-2	138	276
TTM Cash Flow to Firm	16	93	180	63	16	40	265
TTM Free Cash Flow to Firm	48	154	217	78	25	43	267

Multiples (USD)

MCP API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	18.46	10.95	6.69	4.44
EV/EBIT	3.87	1.22	1.26	- -	- -	3.75	4.74
Enterprise Value	134	186	219	1,462	389	517	1,307
Low Price	- -	- -	- -	75	25.56	4.16	28.82
EV/Sales	1.39	0.68	0.66	6.67	1.57	1.08	1.49
EV/EBITDA	3.62	1.17	1.21	170.94	24.2	3.3	4.41
Price/Earnings	- -	- -	- -	- -	- -	3.1	14.79
Price/Earnings Average	- -	- -	- -	-5.88	-8.71	1.72	9.24
Price/Earnings High	- -	- -	- -	-78.81	-30.29	4.05	17.35
Price/Earnings Low	- -	- -	- -	-0.75	-2.43	0.41	2.59
Price/Book Value	- -	- -	- -	-3.32	-0.29	-0.45	-3.66
Price/Book Value Average	- -	- -	- -	-6.89	-0.98	-0.25	-2.29
Price/Book Value High	- -	- -	- -	-92.31	-3.39	-0.59	-4.29
Price/Book Value Low	- -	- -	- -	-0.87	-0.27	-0.06	-0.64
Price/Tangible Book Value	- -	- -	- -	14.67	2.84	1.01	2.7
Price/Tangible Book Value Average	- -	- -	- -	30.43	9.61	0.56	1.68
Price/Tangible Book Value High	- -	- -	- -	407.61	33.39	1.33	3.16
Price/Tangible Book Value Low	- -	- -	- -	3.86	2.68	0.13	0.47
Price/Sales	- -	- -	- -	5.49	0.48	0.34	1.2
Price/Sales Average	- -	- -	- -	11.4	1.61	0.19	0.75
Price/Sales High	- -	- -	- -	152.65	5.6	0.44	1.4
Price/Sales Low	- -	- -	- -	1.45	0.45	0.04	0.21
Price/Cash Flow	- -	- -	- -	23.8	93.67	6.97	4.22
Price/Cash Flow Average	- -	- -	- -	49.38	317.43	3.86	2.64
Price/Cash Flow High	- -	- -	- -	661.47	1,103.17	9.11	4.95
Price/Cash Flow Low	- -	- -	- -	6.26	88.67	0.91	0.74
Price/Free Cash Flow Average	- -	- -	- -	38.3	37.1	3.71	2.77
Price/Free Cash Flow High	- -	- -	- -	513.11	128.95	8.75	5.2
Price/Free Cash Flow Low	- -	- -	- -	4.86	10.36	0.88	0.78
EV/Sales Average	1.39	0.68	0.66	12.57	2.71	0.93	1.04
EV/Sales High	1.39	0.68	0.66	153.82	6.7	1.18	1.7
EV/Sales Low	1.39	0.68	0.66	2.62	1.55	0.79	0.51
EV/EBITDA Average	3.62	1.17	1.21	322.27	41.68	2.84	3.09
EV/EBITDA High	3.62	1.17	1.21	3,943.99	103.1	3.62	5.02
EV/EBITDA Low	3.62	1.17	1.21	67.16	23.81	2.4	1.5
EV/EBIT Average	3.87	1.22	1.26	-602.02	-444.28	3.23	3.32
EV/EBIT High	3.87	1.22	1.26	-7,367.7	-1,098.8	4.11	5.4
EV/EBIT Low	3.87	1.22	1.26	-125.46	-253.72	2.74	1.61
Last Price	- -	- -	- -	285	27	31.69	164.62
High Price	- -	- -	- -	7,920	318	41.44	193.07
Enterprise Value Average	134	186	219	2,756	670	445	914
Enterprise Value High	134	186	219	33,733	1,658	567	1,488
Enterprise Value Low	134	186	219	574	383	377	443

Profitability (USD)

MCP API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	257.69	- -	- -	- -	- -
Return on Assets (%)	- -	43.45	37.71	-102.8	-11.03	9.89	9
Return on Capital (%)	- -	41.12	36.07	- -	- -	-69.77	-22.56
Return on Invested Capital (%)	- -	65.34	51.77	- -	- -	26.09	30.45
Gross Margin (%)	100	57.51	54.08	7.03	14.04	40.89	50.76
EBITDA Margin (%)	38.32	58.05	54.74	3.9	6.49	32.66	33.84
Operating Margin (%)	35.76	55.9	52.43	-2.09	-0.61	28.71	31.49
Incremental Operating Margin (%)	- -	66.94	35.9	- -	- -	59.96	34.87
Pretax Margin (%)	33.06	53.18	51.12	-191.36	-19.58	22.88	27.97
Profit Margin (%)	21.56	38.67	39.99	-193.7	-18.49	10.85	8.09
Net Income to Common Margin (%)	21.56	38.67	39.99	-193.7	-18.49	10.85	8.09
Effective Tax Rate (%)	- -	0.12	0.57	- -	- -	13.68	26.32
Dvd Payout Ratio (%)	43.7	31.89	70.6	-11.63	-12.7	4.68	25.62
Sustainable Growth Rate (%)	- -	- -	75.77	- -	- -	- -	- -

Credit (USD)

MCP API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	120	150	179	267	276	340	351
ST Debt	64	20	13	21	20	28	23
LT Debt	56	130	165	246	256	313	328
Total Debt/EBITDA	3.23	0.94	0.98	31.24	17.15	2.17	1.19
Net Debt/EBITDA	1.24	0.47	0.29	0.46	1.15	- -	-0.48
Total Debt/EBIT	3.46	0.98	1.03	-58.36	-182.74	2.47	1.27
Net Debt/EBIT	1.33	0.49	0.3	-0.87	-12.26	- -	-0.52
EBITDA to Interest Expense	10.53	24.73	29.29	0.68	0.99	7.86	13.32
EBITDA-CapEx/Interest Expense	1.39	15.22	23.33	-0.49	0.4	7.75	13.21
EBIT to Interest Expense	9.83	23.81	28.05	-0.37	-0.09	6.91	12.4
Interest Expense	4	6	6	12	16	20	22
Common Equity/Total Assets	- -	- -	26.08	-83.99	-102.72	-54.47	-31.16
Long-Term Debt/Equity (%)	110.66	88.03	86.32	204.53	323.21	165.79	77.48
Long-Term Debt/Capital (%)	39.49	61.29	46.14	-346.78	-221.07	792.9	206.08
Long-Term Debt/Total Assets (%)	31.39	42.05	41.9	57	64.2	47.7	35.72
Total Debt/Equity (%)	235.94	101.87	93.2	222.06	348.59	180.5	82.99
Total Debt/Capital (%)	84.19	70.92	49.82	-376.5	-238.42	863.26	220.72
Total Debt/Total Assets (%)	66.92	48.65	45.24	61.89	69.24	51.93	38.26
Net Debt to Equity	90.93	50.92	27.63	3.3	23.38	-0.12	-33.61
Net Debt/Capital (%)	34.38	40.3	16.43	-3.77	-13.43	18.44	539.7
EBITDA	37	159	181	9	16	157	296
EBITDA-CapEx	5	98	145	-6	7	154	294
Operating Income (Loss)	35	153	174	-5	-2	138	276

Liquidity (USD)

MCP API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.11	0.81	0.96	0.62	0.38	0.26	1.18
Current Ratio	0.63	4.31	4.09	1.79	1.56	1.9	3.41
Quick Ratio	0.61	4.25	4	1.69	1.45	1.79	3.24
CFO/Avg Current Liab	- -	1.67	5.02	1.09	0.02	0.22	1.59
Common Equity/Total Assets	- -	- -	26.08	-83.99	-102.72	-54.47	-31.16
Long-Term Debt/Equity (%)	110.66	88.03	86.32	204.53	323.21	165.79	77.48
Long-Term Debt/Capital (%)	39.49	61.29	46.14	-346.78	-221.07	792.9	206.08
Long-Term Debt/Total Assets (%)	31.39	42.05	41.9	57	64.2	47.7	35.72
Total Debt/Equity (%)	235.94	101.87	93.2	222.06	348.59	180.5	82.99
Total Debt/Capital (%)	84.19	70.92	49.82	-376.5	-238.42	863.26	220.72
Total Debt/Total Assets (%)	66.92	48.65	45.24	61.89	69.24	51.93	38.26
CFO/Total Liabilities	9.44	53.77	85.41	16.25	0.39	4.96	50.12
CFO/CapEx	0.38	1.42	4.7	3.46	0.13	10.05	98.23
Altman's Z-Score	1.01	2.94	3.02	1.68	-0.59	1.17	3.35

Working Capital (USD)

MCP API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	3.8	2.97	2.53	4.09	3.21	3.12
Days Sales Outstanding	- -	96.09	122.7	144.04	89.24	113.63	117.07
Inventory Turnover	- -	88.68	67.07	64.24	61.49	90.92	150.8
Days Inventory Outstanding	- -	4.12	5.44	5.68	5.94	4.01	2.42
Accounts Payable Turnover	- -	16.85	11.67	9.06	8.06	15.86	14.51
Accounts Payable Turnover Days	- -	21.66	31.28	40.3	45.31	23.01	25.15
Cash Conversion Cycle	- -	78.54	96.86	109.41	49.87	94.63	94.35
Inventory to Cash Days	- -	91.97	117.26	138.35	83.3	109.61	114.65
Inventories	1	2	3	4	3	3	3
Raw Materials	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -
Other Inventory	1	2	3	4	3	3	3

Enterprise Value (USD)

MCP API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	1,205	118	161	1,047
- Cash & Cash Equivalents	8	26	36	34	22	41	186
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	23	62	77	24	18	56	94
+ Total Debt	120	150	179	267	276	340	351
Enterprise Value	134	186	219	1,462	389	517	1,307
Total Capital	142	212	358	-71	-116	39	159
Total Debt/Capital (%)	84.19	70.92	49.82	-376.5	-238.42	863.26	220.72
Total Debt / EV	0.89	0.81	0.81	0.18	0.71	0.66	0.27
EV/Sales	1.39	0.68	0.66	6.67	1.57	1.08	1.49
EV/EBITDA	3.62	1.17	1.21	170.94	24.2	3.3	4.41
EV/EBIT	3.87	1.22	1.26	- -	- -	3.75	4.74
EV/Cash Flow to Firm	8.59	2	1.22	23.03	24.52	12.81	4.94
EV/Free Cash Flow to Firm	2.81	1.21	1.01	18.72	15.34	12.12	4.89
Diluted Market Cap	- -	- -	- -	1,205	118	170	1,112
Diluted Enterprise Value	134	186	219	1,462	389	526	1,372
EV per Share	31.33	43.38	51.11	345.9	89.24	101.57	205.46
TTM Sales	97	274	332	219	248	480	875
TTM EBITDA	37	159	181	9	16	157	296
TTM Operating Income	35	153	174	-5	-2	138	276
TTM Cash Flow to Firm	16	93	180	63	16	40	265
TTM Free Cash Flow to Firm	48	154	217	78	25	43	267

Multiples (USD)

MCP API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	18.46	10.95	6.69	4.44
EV/EBIT	3.87	1.22	1.26	- -	- -	3.75	4.74
Enterprise Value	134	186	219	1,462	389	517	1,307
Low Price	- -	- -	- -	75	25.56	4.16	28.82
EV/Sales	1.39	0.68	0.66	6.67	1.57	1.08	1.49
EV/EBITDA	3.62	1.17	1.21	170.94	24.2	3.3	4.41
Price/Earnings	- -	- -	- -	- -	- -	3.1	14.79
Price/Earnings Average	- -	- -	- -	-5.88	-8.71	1.72	9.24
Price/Earnings High	- -	- -	- -	-78.81	-30.29	4.05	17.35
Price/Earnings Low	- -	- -	- -	-0.75	-2.43	0.41	2.59
Price/Book Value	- -	- -	- -	-3.32	-0.29	-0.45	-3.66
Price/Book Value Average	- -	- -	- -	-6.89	-0.98	-0.25	-2.29
Price/Book Value High	- -	- -	- -	-92.31	-3.39	-0.59	-4.29
Price/Book Value Low	- -	- -	- -	-0.87	-0.27	-0.06	-0.64
Price/Tangible Book Value	- -	- -	- -	14.67	2.84	1.01	2.7
Price/Tangible Book Value Average	- -	- -	- -	30.43	9.61	0.56	1.68
Price/Tangible Book Value High	- -	- -	- -	407.61	33.39	1.33	3.16
Price/Tangible Book Value Low	- -	- -	- -	3.86	2.68	0.13	0.47
Price/Sales	- -	- -	- -	5.49	0.48	0.34	1.2
Price/Sales Average	- -	- -	- -	11.4	1.61	0.19	0.75
Price/Sales High	- -	- -	- -	152.65	5.6	0.44	1.4
Price/Sales Low	- -	- -	- -	1.45	0.45	0.04	0.21
Price/Cash Flow	- -	- -	- -	23.8	93.67	6.97	4.22
Price/Cash Flow Average	- -	- -	- -	49.38	317.43	3.86	2.64
Price/Cash Flow High	- -	- -	- -	661.47	1,103.17	9.11	4.95
Price/Cash Flow Low	- -	- -	- -	6.26	88.67	0.91	0.74
Price/Free Cash Flow Average	- -	- -	- -	38.3	37.1	3.71	2.77
Price/Free Cash Flow High	- -	- -	- -	513.11	128.95	8.75	5.2
Price/Free Cash Flow Low	- -	- -	- -	4.86	10.36	0.88	0.78
EV/Sales Average	1.39	0.68	0.66	12.57	2.71	0.93	1.04
EV/Sales High	1.39	0.68	0.66	153.82	6.7	1.18	1.7
EV/Sales Low	1.39	0.68	0.66	2.62	1.55	0.79	0.51
EV/EBITDA Average	3.62	1.17	1.21	322.27	41.68	2.84	3.09
EV/EBITDA High	3.62	1.17	1.21	3,943.99	103.1	3.62	5.02
EV/EBITDA Low	3.62	1.17	1.21	67.16	23.81	2.4	1.5
EV/EBIT Average	3.87	1.22	1.26	-602.02	-444.28	3.23	3.32
EV/EBIT High	3.87	1.22	1.26	-7,367.7	-1,098.8	4.11	5.4
EV/EBIT Low	3.87	1.22	1.26	-125.46	-253.72	2.74	1.61
Last Price	- -	- -	- -	285	27	31.69	164.62
High Price	- -	- -	- -	7,920	318	41.44	193.07
Enterprise Value Average	134	186	219	2,756	670	445	914
Enterprise Value High	134	186	219	33,733	1,658	567	1,488
Enterprise Value Low	134	186	219	574	383	377	443

Shares Outstanding	4	4	4	4	5	6	7
Diluted Weighted Avg Shares	4	4	4	4	4	5	7
Basic Weighted Avg Shares	4	4	4	4	4	5	6
Revenue per Share	22.62	63.85	77.25	51.88	56.79	94.28	137.59
EBITDA per Share	8.67	37.07	42.29	2.02	3.69	30.79	46.55
Operating Income per Share	8.09	35.69	40.5	-1.08	-0.35	27.07	43.33
Basic EPS, GAAP	4.88	24.69	30.9	-100.5	-10.5	10.23	11.13
Basic EPS from Cont Ops	7.48	33.92	39.27	-102.38	-9.96	18.62	28.35
Diluted EPS, GAAP	4.88	24.69	30.9	-100.5	-10.5	9.69	10.48
Diluted EPS from Cont Ops	7.48	33.92	39.27	-102.38	-9.96	17.64	26.7
Dividend per Share	4.4	13.76	33.63	12.12	1.2	1.26	11.68
Cash Flow per Share	2.83	20.2	40.41	11.97	0.29	4.55	39
Free Cash Flow per Basic Share	-4.7	5.94	31.81	8.51	-1.89	4.1	38.61
Cash & Equivalents per Share	1.87	5.95	8.42	8.1	5.05	7.98	29.17
Book Value per Share	- -	- -	23.98	-85.8	-93.81	-70.12	-44.99
Tangible Book Value per Share	11.58	34.07	44.22	19.43	9.52	31.25	61.04

Nutex Health, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)